MYCN and Duchenne muscular dystrophy: We also tested the antineoplastic activity of piperacetazine in a second mouse model where PAX3::FOXO1 is expressed under a doxycycline-regulated promoter in an immortalized human Duchenne muscular dystrophy myoblast cell line (Dbt) expressing MYCN (17).